ITM Isotope Technologies has provided more detail on how its lead radiotherapy bested the standard of care in a recent phase 3 study while revealing that the candidate was unable to prove a ...

After 20 years of building radioisotope expertise as a manufacturer and supplier, German firm ITM Isotope Technologies is ready to take center stage with drugs of its own. ITM’s lead ...

Proceeds to support development of ITM’s targeted radiopharmaceutical pipeline and preparations for potential market launch of phase III lead candidate, ITM-11, as it nears clinical read-out Funds ...

When the history of green hydrogen is written, the completion of the world’s first gigawatt-scale electrolyser factory might well be seen as a turning point. ITM Power’s new 1GW plant, in Sheffield, ...

Allison DeAngelis is the East Coast biotech and venture capital reporter at STAT, reporting where scientific ideas and money meet. She is also co-host of the weekly biotech podcast, The Readout Loud.

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.

ITM Power PLC (ITMPF) achieves its highest half-year revenue, while navigating legacy contract issues and inflationary pressures.